Efficacy and safety of sildenafil citrate in Pulmonary Arterial Hypertension (PAH): Results of a multinational, randomized, double-blind, placebo-controlled trial
Author(s) -
Lewis J. Rubin,
Gary Burgess,
Tamiza Parpia,
David B. Badesch
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.03.260
Subject(s) - sildenafil , medicine , placebo , adverse effect , randomization , clinical endpoint , placebo controlled study , cgmp specific phosphodiesterase type 5 , anesthesia , randomized controlled trial , pulmonary hypertension , cardiology , double blind , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom